Abstract
The Diagnostic and Statistical Manual, fourth edition, of the American Psychiatric Association (DSM-IV) has defined mental health disorders as conditions characterized by deregulation of mood, thought, and/or behaviour. The global burden of disease attributable to neuropsychiatric conditions is 13.8 %. Depression alone accounts for 7 % of the disease burden and is among the leading causes of disability. The World Health Organization (WHO) has predicted that by 2030, neuropsychiatric conditions will cause the greatest overall increase in disability-adjusted life years (DALYs), with economic consequences both in terms of direct (outpatient care, drug costs, and hospitalization) and indirect costs. This chapter aims to review the current evidences regarding public mental health, helping health professionals and stakeholders to promote best practices in terms of prevention. In this chapter, we describe the most prevalent mental health disorders: mood disorders, in particular depressive disorder, anxiety disorders, schizophrenia, Alzheimer’s disease, and other dementias.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO (2001) Strengthening mental health promotion. https://apps.who.int/inf-fs/en/fact220.html. Accessed 7 Aug 2013
Center for Disease Control and Prevention. Mental illness. http://www.cdc.gov/mentalhealth/basics/mental-illness.htm. Accessed 3 Aug 2013
ICD-10 Chapter Mental and behavioural disorders. http://www.who.int/classifications/icd/en/GRNBOOK.pdf. Accessed 6 Aug 2013
WHO (2004) Projections of mortality and global burden of disease 2004–2030. http://www.who.int/healthinfo/global_burden_disease/projections2004/en/index.html. Accessed 2 Aug 2013
Prince M, Patel V, Saxena S et al (2007) No health without mental health. Lancet 370(9590):859–877
Center of Disease Control (CDC). http://www.cdc.gov/mentalhealth/basics/mental-illness/depression.htm. Accessed 6 Aug 2013
Center of Disease Control (CDC). http://www.cdc.gov/mentalhealth/basics/mental-illness/anxiety.htm. Accessed 6 Aug 2013
Martin EA (2010) Schizophrenia concise medical dictionary. Oxford University Press
CDC. http://www.cdc.gov/mentalhealth/basics/mental-illness/dementia.htm. Accessed 6 Aug 2013
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edn. American Psychiatric Association, Washington, D. C
Ormel J, Vonkorff M, Oldehinkel AJ, Simon G, Tiemens BG, Ustün TB (1999) Onset of disability in depressed and non-depressed primary care patients. Psychol Med 29(4):847–853
World Health Organization. Mental health—depression. http://www.who.int/mental_health/management/depression/en/. Accessed 1 Aug 2013
Murray CJ, Lopez AD (1996) Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 274:740–743
Murray CJ, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge
World Health Organization. Mental health—depression. http://www.who.int/mental_health/management/depression/en/. Accessed 1 Aug 2013
Sobocki P, Jönsson B, Angst J, Rehnberg C (2006) Cost of depression in Europe. J Ment Health Policy Econ 9(2):87–98
Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D (2003) Cost of lost productive work time among US workers with depression. J Am Med Assoc 289(23):3135–3144
Kessler RC, DuPont RL, Berglund P, Wittchen HU (1999) Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 156(12):1915–1923
Brown HE, Pearson N, Braithwaite RE, Brown WJ, Biddle SJ (2013) Physical activity interventions and depression in children and adolescents: a systematic review and meta-analysis. Sports Med 43(3):195–206
Reynolds CF 3rd, Cuijpers P, Patel V et al (2012) Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health 33:123–135
Beardslee WR, Gladstone TR, Wright EJ, Cooper AB (2003) A family-based approach to the prevention of depressive symptoms in children at risk: evidence of parental and child change. Pediatrics 112(2):e119–e131
WHO. http://www.who.int/mental_health/evidence/en/prevention_of_mental_disorders_sr.pdf. Accessed 25 Aug 2013
Angst J (1995) History and epidemiology of panic. Eur Psychiatry 10(Suppl 2):57s–59s
Kessler RC, Calabrese JR, Farley PA et al (2013) Composite international diagnostic interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med 43(8):1625–1637
Cairney J, Corna LM, Veldhuizen S, Kurdyak P, Streiner DL (2008) The social epidemiology of affective and anxiety disorders in later life in Canada. Can J Psychiatry 53(2):104–111
Hendriks SM, Spijker J, Licht CM, Beekman AT, Penninx BW (2013) Two-year course of anxiety disorders: different across disorders or dimensions? Acta Psychiatr Scand 128(3):212–221
Wardenaar KJ, Giltay EJ, van Veen T, Zitman FG, Penninx BW (2012) Dimensions of the inventory of depressive symptomatology as predictors of the course of depressive and anxiety disorders. J Psychiatr Res 46(12):1655–1661
Roest AM, Heideveld A, Martens EJ, de Jonge P, Denollet J (2013) Symptom dimensions of anxiety following myocardial infarction: associations with depressive symptoms and prognosis. Health Psychol doi:10.1037/a0034806
Beesdo-Baum K, Knappe S (2012) Developmental epidemiology of anxiety disorders. Child Adolesc Psychiatr Clin N Am 21(3):457–478
Schultz SH, North SW, Shields CG (2007) Schizophrenia: a review. Am Fam Physician 75(12):1821–1829
Mandal MK, Nizamie SH (2004) Current developments in schizophrenia. Allied Publishers, New Delhi
World Health Organization. Mental health—schizophrenia. http://www.who.int/mental_health/management/schizophrenia/en/. Accessed 23 Jul 2013
Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW (2005) No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology 19(6):778–786
Reichenberg A, Harvey PD, Bowie CR et al (2009) Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 35(5):1022–1029
Caspi A, Reichenberg A, Weiser M et al (2003) Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 65(2–3):87–94
Keefe RS, Bilder RM, Harvey PD et al (2006) Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacol 31(9):2033–2046
Kovess-Masféty V, Wiersma D, Xavier M et al (2006) Needs for care among patients with schizophrenia in six European countries: a one-year follow-up study. Clin Pract Epidemiol Ment Health 2:22
Mangalore R, Knapp M (2007) Cost of schizophrenia in England. J Ment Health Policy Econ 10(1):23–41
London School of Economics—PSSR (2012) Effective interventions in schizophrenia—the economic case. http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/LSE-economic-report-FINAL-12-Nov.pdf. Accessed 23 Jul 2013
National Institute for Health and Care Excellence (NICE) (2010) Schizophrenia—the NICE guideline on core interventions in the treatment and management of schizophrenia in adults in primary and secondary care, updated edition. http://www.nice.org.uk/nicemedia/live/11786/43607/43607.pdf. Accessed 23 Jul 2013
Jones C, Hacker D, Cormac I, Meaden A, Irving CB (2012) Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 4:CD008712
Alzheimer’s Disease International (2010) World Alzheimer report 2010. The global economic impact of dementia. http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf. Accessed 24 Jul 2013
Alzheimer’s association. 2009 Alzheimer’s disease facts and figures. http://www.alz.org/national/documents/report_alzfactsfigures2009.pdf. Accessed 24 Jul 2013
Bassil N, Mollaei C (2012) Alzheimer’s dementia: a brief review. J Med Liban 60(4):192–199
Tampellini D, Rahman N, Lin MT, Capetillo-Zarate E, Gouras GK (2011) Impaired β-amyloid secretion in Alzheimer’s disease pathogenesis. J Neurosci 31(43):15384–15390
Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752
Román G, Pascual B (2012) Contribution of neuroimaging to the diagnosis of Alzheimer’s disease and vascular dementia. Arch Med Res 43(8):671–676
Korczyn AD, Vakhapova V, Grinberg LT (2012) Vascular dementia. J Neurol Sci 322(1–2):2–10
Román GC (2002) Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 203–204:7–10
Alzheimer’s Disease International (2010) World Alzheimer report 2010. The global economic impact of dementia. http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf. Accessed 24 Jul 2013
Alzheimer’s Disease International (2009) World Alzheimer report 2009
Roman GC The epidemiology of vascular dementia. In: Duyckaerts C, Litvan I (eds) Dementias -Handbook of clinical neurology, vol 89 (3rd series), Elsevier Edinburgh, 2008, pp 639–658
Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN (2013) Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer’s disease and vascular dementia. Curr Alzheimer Res 10(6):642–653
de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535
Rosso SM, DonkerKaat L, Baks T et al (2003) Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126(Pt 9):2016–2022
World Health Organization & Alzheimer’s Disease International (2012) Dementia: a public health priority. http://apps.who.int/iris/bitstream/10665/75263/1/9789241564458_eng.pdf Accessed 24 Jul 2013
Alzheimer’s Disease International (2012) Initial release of Global Burden of Disease 2010 Study in Lancet. http://www.alz.co.uk/media/121213 Accessed 24 Jul 2013
Pinquart M, Sorensen S (2006) Helping caregivers of persons with dementia. Which interventions works and how large are their effects? Int Psychogeriatr 8:577–595
Smits CH, de Lange J, Dröes RM, Meiland F, Vernooij-Dassen M, Pot AM (2007) Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review. Int J Geriatr Psychiatry 22(12):1181–1193
Brodaty H, Green A, Koschera A (2003) Meta-analysis of psychosocial interventions for caregivers of people with dementia. J Am Geriatr Soc 51:657–664
Lee H, Cameron M (2004) Respite care for people with dementia and their carers. Cochrane Database Syst Rev 2004:CD004396
Spijker A, Vernooij-Dassen M, Vasse E et al (2008) Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis. J Am Geriatr Soc 56(6):1116–1128
Olazarán J, Reisberg B, Clare L et al (2010) Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 30(2):161–178
Mittelman MS, Ferris SH, Steinberg G et al (1993) An intervention that delays institutionalization of Alzheimer’s disease patients: treatment of spouse-caregivers. Gerontologist 33(6):730–740
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B (1996) A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial. JAMA 276(21):1725–1731
Mittelman MS, Haley WE, Clay OJ, Roth DL (2006) Improving caregiver well being delays nursing home placement of patients with Alzheimer disease. Neurology 67(9):1592–1599
Mittelman MS, Roth DL, Clay OJ, Haley WE (2007) Preserving health of Alzheimer caregivers: impact of a spouse caregiver intervention. Am J Geriatr Psychiatry 15(9):780–789
Mittelman MS, Brodaty H, Wallen AS, Burns A (2008) A three-country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: effects on caregiver depression. Am J Geriatr Psychiatry 16(11):893–904
Sörensen S, Duberstein P, Gill D, Pinquart M (2006) Dementia care: mental health effects, intervention strategies, and clinical implications. Lancet Neurol 5(11):961–973
Gallagher-Thompson D, Coon D (2007) Evidence-based psychological treatments for distress in family caregivers of older adults. Psychol Aging 22:37–51
Hepburn K, Lewis M, Tornatore J, Sherman CW, Bremer KL (2007) The Savvy Caregiver program: the demonstrated effectiveness of a transportable dementia caregiver psychoeducation program. J Gerontol Nurs 33(3):30–36
Burgio LD, Collins IB, Schmid B, Wharton T, McCallum D, Decoster J (2009) Translating the REACH caregiver intervention for use by area agency on aging personnel: the REACH OUT program. Gerontologist 49(1):103–116
Teri L, Logsdon RG, Uomoto J, McCurry SM (1997) behavioural treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 52(4):P159–P166
Gitlin LN, Winter L, Corcoran M, Dennis MP, Schinfeld S, Hauck WW (2003) Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative. Gerontologist 43(4):532–546
Farran C, Gilley D, McCann J, Bienias J, Lindeman D, Evans D (2004) Psychosocial interventions to reduce depressive symptoms of dementia caregivers: a randomized clinical trial comparing two approaches. J Mental Health Aging 10:337–350
Gitlin LN, Hauck WW, Dennis MP, Winter L (2005) Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer’s disease and related disorders. J Gerontol A Biol Sci Med Sci 60(3):368–374
Teri L, McCurry SM, Logsdon R, Gibbons LE (2005) Training community consultants to help family members improve dementia care: a randomized controlled trial. Gerontologist 45(6):802–811
Gonyea J, O’Connor M, Boyle P (2006) Project CARE: a randomized controlled trial of a behavioural intervention group for Alzheimer’s disease caregivers. Gerontologist 46:827–832
Gitlin LN, Winter L, Burke J, Chernett N, Dennis MP, Hauck WW (2008) Tailored activities to manage neuropsychiatric behaviours in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry 16(3):229–239
Belle SH, Burgio L, Burns R et al (2006) Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med 145(10):727–738
Brodaty H, Gresham M, Luscombe G (1997) The Prince Henry Hospital dementia caregivers’ training program. Int J Geriatr Psychiatry 12:183–192
Gallagher-Thompson D, Steffen A (1994) Comparative effects of cognitive/behavioural and brief psychodynamic psychotherapies for depressed in family caregivers. J Consult Clin Psychol 62(3):543–549
Charlesworth GM, Reichelt FK (2004) Keeping conceptualizations simple: examples with family carers of people with dementia. Behav Cogn Psychoth 32(4):401–409
Auer RS, Span E, Donabauer Y, Reisberg B (2009) A 10-day training program for persons with dementia and their carers: a practical nonpharmacological treatment program. Alzheimer’s Dementia 5(4)(Suppl 1):406
Auer RS, Zehetner F, Donabauer Y, Span E (2007) Entlastung pflegender Angehöriger: Ein Programm der M.A.S Alzheimerhilfe. Zeitschrift für Gerontopsychologie Psychiatrie 20(2/3):169–174
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cadeddu, C., Ianuale, C., Lindert, J. (2015). Public Mental Health. In: Boccia, S., Villari, P., Ricciardi, W. (eds) A Systematic Review of Key Issues in Public Health. Springer, Cham. https://doi.org/10.1007/978-3-319-13620-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-13620-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13619-6
Online ISBN: 978-3-319-13620-2
eBook Packages: MedicineMedicine (R0)